Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PTC Therapeutics
PTCT
$5.93B
| $18.3M | 0.02% |
677,501
+122,296
| +22% | +$3.1M |
|
927
Ford
F
$55.5B
| $18.3M | 0.02% |
1,651,588
-5,028,560
| -75% | -$56.7M |
|
928
Nexa Resources
NEXA
$2.02B
| $18.3M | 0.02% |
1,044,307
-376,781
| -27% | -$7.4M |
|
|
MDP
929
DELISTED
Meredith Corporation
MDP
| $18.2M | 0.02% |
338,701
+226,187
| +201% | +$13.4M |
|
|
VG
930
DELISTED
Vonage Holdings Corporation
VG
| $18.2M | 0.02% |
1,708,111
-1,280,897
| -43% | -$13.7M |
|
931
CALL
General Motors
GM
$76.3B
| $18.2M | 0.02% |
+500,000
| New | +$20.3M |
|
932
Orion
OEC
$340M
| $18.1M | 0.02% |
667,798
-71,025
| -10% | -$1.98M |
|
933
CALL
Medtronic
MDT
$119B
| $18.1M | 0.02% |
225,000
+125,000
| +125% | +$10.3M |
|
934
Dine Brands
DIN
$457M
| $18M | 0.02% |
275,019
+167,678
| +156% | +$10.2M |
|
935
Silicon Laboratories
SLAB
$7.28B
| $18M | 0.02% |
200,266
+130,928
| +189% | +$12.3M |
|
936
CALL
Merck
MRK
$372B
| $18M | 0.02% |
345,840
+83,840
| +32% | +$4.53M |
|
|
PPBI
937
DELISTED
Pacific Premier Bancorp
PPBI
| $18M | 0.02% |
447,110
-491,211
| -52% | -$20.5M |
|
|
DPLO
938
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $18M | 0.02% |
891,716
+745,162
| +508% | +$17.4M |
|
939
Trinity Industries
TRN
$2.37B
| $17.9M | 0.02% |
761,723
-1,379,277
| -64% | -$34M |
|
940
McGrath RentCorp
MGRC
$2.85B
| $17.9M | 0.02% |
332,908
-5,490
| -2% | -$274K |
|
941
uniQure
QURE
$3.29B
| $17.9M | 0.02% |
759,585
+538,031
| +243% | +$11.7M |
|
|
MANT
942
DELISTED
Mantech International Corp
MANT
| $17.8M | 0.02% |
321,164
+299,659
| +1,393% | +$16M |
|
943
Lincoln Electric
LECO
$15.4B
| $17.8M | 0.02% |
197,896
-32,385
| -14% | -$3.02M |
|
944
OneMain Financial
OMF
$7.23B
| $17.8M | 0.02% |
594,326
+499,968
| +530% | +$15.9M |
|
945
Oracle
ORCL
$410B
| $17.8M | 0.02% |
388,458
+186,470
| +92% | +$9.27M |
|
946
Coca-Cola Europacific Partners
CCEP
$48.6B
| $17.8M | 0.02% |
426,497
+142,625
| +50% | +$5.62M |
|
947
Mammoth Energy Services
TUSK
$150M
| $17.7M | 0.02% |
553,252
+404,318
| +271% | +$10.1M |
|
948
Eastman Chemical
EMN
$8.31B
| $17.7M | 0.02% |
167,787
-111,005
| -40% | -$11.2M |
|
949
AtriCure
ATRC
$2.51B
| $17.6M | 0.02% |
859,871
+122,911
| +17% | +$2.22M |
|
950
Hanmi Financial
HAFC
$926M
| $17.6M | 0.02% |
573,555
+120,190
| +27% | +$3.75M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.